Vaxcyte (PCVX) CFO Andrew Guggenhime Surrenders 7,155 Shares

What Happened
Andrew Guggenhime, President and CFO of Vaxcyte, surrendered 7,155 shares (disposition code F) at $60.36 per share—total value ~$431,876—on September 8, 2026 to satisfy tax withholding obligations arising from RSU vesting. This was a share surrender to cover taxes (routine), not an open-market sale or a purchase.

Key Details

• Transaction date: 2026-09-08; Filing date (Form 4): 2026-09-09 (timely filing).
• Shares surrendered/disposed: 7,155 at $60.36 each; total value ≈ $431,876.
• Transaction code F indicates shares were surrendered to cover tax withholding on vested RSUs (cashless/withholding settlement).
• Ownership after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — shares surrendered to issuer to cover tax withholding on RSU vesting; F2 — some shares are held by ALG 2025 GRAT HOLDINGS LLC, wholly owned by a grantor retained annuity trust for which Guggenhime is annuitant and trustee.

Context
This is a routine tax-withholding share surrender tied to RSU vesting and does not necessarily signal a change in the insider’s view of the company. Such transactions are common when awards vest and taxes are settled in shares rather than cash.